SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-242120
Filing Date
2019-09-10
Accepted
2019-09-10 16:57:57
Documents
2
Period of Report
2019-09-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d794217d8k.htm 8-K 16987
2 EXHIBIT 99.1 d794217dex991.htm EX-99.1 8842
  Complete submission text file 0001193125-19-242120.txt   26930
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Filer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38939 | Film No.: 191085909
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1